GlaxoSmithKline Pharmaceuticals
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Pharmaceuticals
| Finished Products | --------------------------- in Rs. Cr. --------------------------- | Dec 2008 | |||
| Product Name | Unit | Installed Capacity |
Production Quantity |
Sales Quantity |
Sales Value |
| Tablets & Capsules | Millions Numbers | 6,950 | 8,707.00 | 9,218.00 | 813.10 |
| Solids Incl. Powders & Ointments | Metric Tonnes | 2,225 | 2,257.00 | 3,227.00 | 364.40 |
| Liquids - Orals, Topicals, Parenterals & Malt | Kilolitres | 8,400 | 6,359.00 | 7,276.00 | 289.04 |
| Antibiotic Vials | Thousands Numbers | 5,000 | 4,976.00 | 10,241.00 | 129.27 |
| Vaccines | - | NA | NA | 1,427.00 | 83.49 |
| Chemicals & Drugs (Bulk) | Metric Tonnes | 184 | 23.00 | 188.00 | 47.23 |
| Aerosols | Thousands Numbers | 3,000 | 1,097.00 | 1,189.00 | 25.04 |
| Other Services | - | NA | NA | NA | 6.94 |
| Commission | - | NA | NA | NA | 2.57 |
| Other Fiscal Benefits | - | NA | NA | NA | 1.56 |
| Total | 1,762.64 | ||||
![]() | |||||
| Source : Religare Technova | |||||
![]() | |||||




Online










